Related Experiment Videos

Variable expression of Parkinson's disease: a base-line analysis of the DATATOP cohort. The Parkinson Study Group

J Jankovic1, M McDermott, J Carter

  • 1Department of Neurology, Baylor College of Medicine, Houston, TX 77030.

Neurology
|October 1, 1990
PubMed

Insights

Parkinson's disease (PD) shows clinical heterogeneity. Early-onset PD progresses slower and has better cognition than late-onset PD. PD subtypes exist, impacting disability and impairment.

Area of Science:

  • Neurology
  • Clinical Neuroscience
  • Movement Disorders

Background:

  • Parkinson's disease (PD) exhibits significant clinical heterogeneity.
  • Understanding this heterogeneity is crucial for personalized treatment strategies.
  • The DATATOP database offers a valuable resource for studying early PD progression.

Purpose of the Study:

  • To explore clinical heterogeneity in early untreated Parkinson's disease.
  • To identify distinct clinical subtypes and their progression patterns.
  • To investigate the impact of age of onset and symptom presentation on PD disability.

Main Methods:

  • Analysis of the DATATOP database (N=800) for early untreated Parkinson's disease patients.
  • Comparison of clinical characteristics based on age of onset (early vs. late).
  • Categorization and comparison of patients based on disease progression rate (malignant vs. benign) and dominant symptoms (tremor vs. PIGD).

Main Results:

  • Early-onset PD (≤40 years) progressed significantly slower and maintained better cognitive function than late-onset PD (≥70 years).
  • Bradykinesia and postural instability and gait difficulty (PIGD) were more common in rapidly progressing ('malignant') PD.
  • PIGD-dominant PD showed greater functional impairment (intellectual, motor, occupational) compared to tremor-dominant PD.
  • Higher depression scores were observed in Stage II compared to Stage I PD patients.

Conclusions:

  • Parkinson's disease presents with distinct clinical subtypes influencing disease progression and patient outcomes.
  • Age at onset is a significant factor in PD progression and cognitive function.
  • Symptom presentation (bradykinesia/PIGD vs. tremor) and progression rate are associated with varying levels of functional disability and impairment.

Related Concept Videos